Germline variants alter immune surveillance.

The article discusses a study on the role of germline variants in cancer immunoediting conducted by Houlahan et al., published in the journal Science. The study highlights how germline variants contribute to the formation of human breast cancer by modulating immunoediting, suggesting that the number of immunogenic germline epitopes in certain oncogenes influences tumor development and patient outcomes, with implications for personalized immunotherapy.